Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
"This book showcases exemplars of teaching strategies and innovation from national and international leaders in academia that advance and elevate the science and art of teaching both at the undergraduate and graduate level. Behind every strategy described in this book is an educator who has taken g…
Contents:; Attacking the Basics: What Fuels a Wound -- The Phases of Wound Healing and Types of Wound Closure -- Acute Wounds -- Chronic Lower Extremity Wounds -- Pressure Injuries -- Atypical, Complex Wounds -- Assessing Wounds -- Documenting and Photographing Wounds -- Selecting the Correct Dress…
Contents:; Evidence-based practice / Kathleen M. White -- The science of translation and major frameworks / Kathleen M. White -- Change theories for translation / Kathleen M. White -- Translation of evidence for improving clinical outcomes / Julie Stanik-Hutt -- Translation of evidence for improvin…
Contents:; Introduction to Research -- Finding the Big Problem -- From Hypothesis to Aim/Purpose -- Why We Review the Literature -- The Theoretical Framework -- Research Design / Tom Heinzen -- Qualitative, Quantitative and Mixed Methods Research Designs -- Methods of data collection -- Reliability…
Contents:; 1. Epidemiology, pathophysiology and classification -- 2. Clinical presentation -- 3. Diagnosis -- 4. Management -- 5. Treatment of associated conditions -- 6. Emerging research and treatment -- Useful resources.
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
Contents:; Biologics and the need for biosimilars -- Why do we need biosimilars? -- How is the quality of biosimilar medicines assured? -- Legal issues -- Switching, interchangeability and extrapolation -- Safety and pharmacovigilant -- Global issues -- Formulary considerations: pharmacy issues -- …
Contents:; Marketing Yourself as a Clinical Nurse Leader -- Integration into CNL Practice : Preparing to Lead -- Leadership Within a Complex Environment -- Microsystem Assessment and the 5P?s -- Utilizing Evidence to Improve Practice -- Utilizing Data and Quality Improvement Principles -- Coordinat…
Contents:; 1: GENETIC MUTATIONS AND BIOMARKERS -- 2: UNDERSTANDING NEXT-GENERATION SEQUENCING -- 3: ELEMENTS OF COMPREHENSIVE GENOMIC PROFILES -- 4: ROLE IN PRECISION ONCOLOGY -- 5: PREDICTIVE AND PROGNOSTIC BIOMARKERS -- 6: OVERCOMING BARRIERS TO GENOTYPE-DIRECTED THERAPY